1 – 23 of 23
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The clinical spectrum of ataxia telangiectasia in a cohort in Sweden
(
- Contribution to journal › Article
- 2023
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
-
Mark
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease
(
- Contribution to journal › Letter
-
Mark
Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease : a study of linked Swedish National Registries (2002–2019)
(
- Contribution to journal › Article
-
Mark
A Paradigm Shift in the Management of Patients with Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Structural-functional properties of direct-pathway striatal neurons at early and chronic stages of dopamine denervation
2023) In European Journal of Neuroscience(
- Contribution to journal › Article
- 2021
-
Mark
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism
(
- Contribution to journal › Article
-
Mark
The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria
(
- Contribution to journal › Article
- 2020
-
Mark
New generation genetic testing entering the clinic
(
- Contribution to journal › Article
-
Mark
Inborn Errors of Metabolism in Adults : Two Patients with Movement Disorders Caused by Glutaric Aciduria Type 1
(
- Contribution to journal › Article
-
Mark
Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia
(
- Contribution to journal › Article
- 2019
-
Mark
Significance and translational value of high-frequency cortico-basal ganglia oscillations in Parkinson's disease
(
- Contribution to journal › Article
- 2018
-
Mark
On the neuronal circuitry mediating l-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Eye movement disorders and neurological symptoms in late-onset inborn errors of metabolism
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
(
- Contribution to journal › Article
- 2015
-
Mark
Myoclonus in childhood-onset neurogenetic disorders : The importance of early identification and treatment
(
- Contribution to journal › Article
- 2014
-
Mark
Neurodegenerative disease : Mapping the natural history of Huntington disease
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Role of Gα(olf) in Familial and Sporadic Adult-Onset Primary Dystonia.
(
- Contribution to journal › Article
- 2012
-
Mark
Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease
(
- Contribution to journal › Article
-
Mark
MyD88 deficiency results in both cognitive and motor impairments in mice
(
- Contribution to journal › Article
- 2001
-
Mark
Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
- 2000
-
Mark
High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat
(
- Contribution to journal › Article
- 1999
-
Mark
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
(
- Contribution to journal › Article